Description

Product Description :

PT141 10mg/vial

PT 141 (Bremelanotide) is a synthetic cyclic heptapeptide drug that shows unique potential in the treatment of sexual dysfunction. Its development stems from the unremitting efforts of researchers to improve the quality of life of patients with sexual dysfunction. After years of research and experimentation, it has gradually come into the public view.

In terms of its mechanism of action, PT 141 is a melanocortin receptor agonist that mainly acts on melanocortin receptors in the central nervous system, particularly the MC3R and MC4R receptor subtypes. Once PT 141 binds to these receptors, it can activate relevant neural pathways, promote the release and transmission of neurotransmitters, and thus have a positive impact on sexual function. In men, it can effectively improve erectile dysfunction. By stimulating relevant nerve signals, it relaxes the smooth muscles of the corpus cavernosum of the penis, increases blood flow, and enables penile erection. In women, PT 141 mainly regulates sexual desire. Through the regulation of the neural pathways involved in the sexual response in the brain, it enhances female sexual desire and alleviates the problems caused by decreased sexual desire.

COA